Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Oncology (Williston Park, N.Y.)
|
March 8, 2012
Nodal marginal zone lymphoma: what do we really know?
Vaishalee P Kenkre, Brad Kahl
Clinical Lymphoma & Myeloma
|
September 26, 2009
Burkitt lymphoma/leukemia: improving prognosis
Vaishalee P Kenkre, Wendy Stock
Expert Review of Hematology
|
November 19, 2010
Follicular lymphoma: emerging therapeutic strategies
Vaishalee P Kenkre, Brad S Kahl
Current Hematologic Malignancy Reports
|
June 13, 2012
The future of B-cell lymphoma therapy: the B-cell receptor and its downstream pathways
Vaishalee P Kenkre, Brad S Kahl
Cancer Journal (Sudbury, Mass.)
|
September 26, 2012
What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma?
Vaishalee P Kenkre, Brad S Kahl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2025
Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity
Priyanka A Pophali, Vaishalee P Kenkre, Christi Ann Hayes
Case Reports in Medicine
|
December 10, 2021
Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren's Syndrome: When in Doubt, Use the PLASMIC Score
Devon D Miller, Joseph A Krenzer, Vaishalee P Kenkre, et al.
Leukemia Research
|
July 20, 2020
Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications
Christopher R D'Angelo, Aric Hall, Kaitlin M Woo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2015
Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma
Vaishalee P Kenkre, Fangxin Hong, James R Cerhan, et al.
Leukemia & Lymphoma
|
August 16, 2023
TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience
Vaishalee P Kenkre, Kristin Bradley, Arissa Milton, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Oncology (Williston Park, N.Y.)
|
March 8, 2012
Nodal marginal zone lymphoma: what do we really know?
Vaishalee P Kenkre, Brad Kahl
Clinical Lymphoma & Myeloma
|
September 26, 2009
Burkitt lymphoma/leukemia: improving prognosis
Vaishalee P Kenkre, Wendy Stock
Expert Review of Hematology
|
November 19, 2010
Follicular lymphoma: emerging therapeutic strategies
Vaishalee P Kenkre, Brad S Kahl
Current Hematologic Malignancy Reports
|
June 13, 2012
The future of B-cell lymphoma therapy: the B-cell receptor and its downstream pathways
Vaishalee P Kenkre, Brad S Kahl
Cancer Journal (Sudbury, Mass.)
|
September 26, 2012
What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma?
Vaishalee P Kenkre, Brad S Kahl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2025
Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity
Priyanka A Pophali, Vaishalee P Kenkre, Christi Ann Hayes
Case Reports in Medicine
|
December 10, 2021
Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren's Syndrome: When in Doubt, Use the PLASMIC Score
Devon D Miller, Joseph A Krenzer, Vaishalee P Kenkre, et al.
Leukemia Research
|
July 20, 2020
Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications
Christopher R D'Angelo, Aric Hall, Kaitlin M Woo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2015
Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma
Vaishalee P Kenkre, Fangxin Hong, James R Cerhan, et al.
Leukemia & Lymphoma
|
August 16, 2023
TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience
Vaishalee P Kenkre, Kristin Bradley, Arissa Milton, et al.
Page
of 6